Cardiomyopathy Tissue Bank in a Cancer Population
Cardiomyopathy Tissue Bank in a Cancer Population
Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential
 participant.

 The goal of this laboratory research study is to collect and store blood and tissue from
 patients who have a diagnosis of heart disease and may be at a high risk for the development
 of heart failure. This blood may be used in the future to identify genes that may play a role
 in developing congestive heart failure (CHF) from chemotherapy or other sources.

 This is an investigational study. All will be enrolled at MD Anderson.
You will have a one time blood draw of 2 teaspoons of blood for use in future research. This
 blood may be studied in the future to try to find possible genetic or biochemical markers
 that may be the cause of CHF. Your blood will be drawn either on an outpatient basis or
 during a routine visit to the hospital. If you already have a central line or an IV placed,
 the blood will be drawn at these sites to decrease the pain and discomfort of the blood draw.
 The information obtained in this study will not be put into your medical records.
Inclusion Criteria:

 -  Patients who are at high risk for developing Cardiomyopathy or Congestive Heart
 Failure.

 -  Patients two months of age and older.

 Exclusion Criteria:

 -  Those that are not willing to sign an informed consent.